Epoch Investment Partners Inc. boosted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 10.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,030,177 shares of the biopharmaceutical company’s stock after buying an additional 96,193 shares […]
Epoch Investment Partners Inc. increased its stake in Texas Instruments Incorporated (NASDAQ:TXN – Free Report) by 1.9% in the 4th quarter, Holdings Channel reports. The fund owned 929,155 shares of the semiconductor company’s stock after buying an additional 17,560 shares during the quarter. Texas Instruments comprises about 0.7% of Epoch Investment Partners Inc.’s holdings, making […]
Platform Technology Partners lifted its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 23.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,889 shares of the company’s stock after purchasing an additional 4,414 shares during the period. […]
Bain Capital Investors LLC lifted its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 65,679,781 shares of the biotechnology company’s stock after purchasing an additional 5,480,052 shares during the quarter. […]
Compass Rose Asset Management LP acquired a new stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 420,000 shares of the biopharmaceutical company’s stock, valued at approximately $21,550,000. Bristol-Myers Squibb makes up approximately 9.0% of […]